BNKL

 
Common Stock SEC Reporting - Current
OTCQX U.S.
Contact Info
  • 483 Bay Street
  • N105
  • Toronto, ONT M5G 2C9
  • Canada

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2016 10-Q
CIK 0001508381
Fiscal Year End 12/31
OTC Marketplace OTCQX U.S.
Profile Data
SIC - Industry Classification 8011 - Offices and clinics of medical doctors
Incorporated In: DE, USA
Year of Inc. 2010
Employees 30 a/o Jul 10, 2015
Company Officers/Contacts
Peter Bloch CEO
Leslie Markow CFO, IR
Michal Prywata CTO, Founder
Tim McCarthy Chief Commercial Officer
Hermano Igo Krebs Chief Scientific Officer
Company Directors
Peter Bloch Chairman
Dr. Robert Hariri
Marc Marthieu Independent Director
Tim McCarthy
Michal Prywata
Service Providers
Accounting/Auditing Firm
MNP LLP
900- 50 Burnhamthorpe Road West
Sussex Centre
Mississauga, ONT, L5B3C2
Canada
 
Securities Counsel
Ruskin Moscou Faltischek, PC OTCQX Sponsor
1425 RXR Plaza
East Tower, 15th Floor
Uniondale, NY, 11556
United States
 
Investor Relations Firm
Amato and Partners, LLC
90 Park Ave
17th Floor
New York, NY,
United States
 
Company History
  • Sponsored for OTCQX by Ruskin Moscou Faltischek, PC on 8/19/2015.
  • Formerly=Drywave Technologies, Inc. until 2-2015
  • Formerly=Strategic Dental Management Corp until 7-2013
BNKL Security Details
Share Structure
Market Value1 $14,176,681 a/o Jun 23, 2017
Authorized Shares 200,000,000 a/o Jun 14, 2017
Outstanding Shares 48,885,107 a/o Jun 14, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 6,000,063 a/o Aug 13, 2015
Par Value 0.001
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders
Shareholders of Record 210 a/o Jun 30, 2016
Short Selling Data
Short Interest 2,472 (-68.53%)
May 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security